RxDoctor Payments Data

Kenneth Cooke

Pediatric Hematology-Oncology · Baltimore, MDNPI 1104836733

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $167,720 of the $262,787 with a category attached, or 63.8%. Jazz Pharmaceuticals Inc. accounts for 90.2% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2021 at $81,905 and has fallen 99.5% since, to $398 in 2025. Among pediatric hematology-oncology clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$262,787in general payments, 2019–2025

Across 265 payments — averaging $991.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Jazz Pharmaceuticals Inc.$237K
  • Omeros Corporation$15K
  • Sanofi-aventis U.S. LLC$10K
  • Gilead$114
$121,290in research payments, 2019–2025

Across 9 payments — averaging $13,477 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pharmacyclics LLC, An Abbvie Company$64K
  • Jazz Pharmaceuticals Inc.$47K
  • National Marrow Donor Program$10K

What the payments were for

  • Consulting fees$63,40124%
  • Speaking & faculty fees$167,72064%
  • Travel & lodging$25,41510%
  • Food & beverage$6,2502%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Jazz Pharmaceuticals Inc.241$237,122
Omeros Corporation12$15,146
Sanofi-aventis U.S. LLC11$10,405
Gilead1$114

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$262,787 in reported general payments places this provider in the 95th percentile of 52 pediatric hematology-oncology providers in Maryland.

See all pediatric hematology-oncology providers in Maryland

Other pediatric hematology-oncology in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →